Taub Rn

595 total citations
42 papers, 456 citations indexed

About

Taub Rn is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Taub Rn has authored 42 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 10 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Taub Rn's work include Glycosylation and Glycoproteins Research (7 papers), Immunotherapy and Immune Responses (5 papers) and Acute Myeloid Leukemia Research (5 papers). Taub Rn is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Immunotherapy and Immune Responses (5 papers) and Acute Myeloid Leukemia Research (5 papers). Taub Rn collaborates with scholars based in United States and Canada. Taub Rn's co-authors include Mark Baker, Mary Louise Keohan, Scott Z. Fields, Doris B. Tse, Huimin Chung, Alexander Hindenburg, Cathy Shea, L H Van der Ploeg, C Severin and Andrew P. Ferry and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Taub Rn

37 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taub Rn United States	12	173	107	76	72	63	42	456
B B Lozzio United States	11	214 1.2×	147 1.4×	102 1.3×	25 0.3×	84 1.3×	42	491
D Buriot France	9	294 1.7×	152 1.4×	111 1.5×	34 0.5×	97 1.5×	28	571
Noriharu Sato Japan	12	155 0.9×	117 1.1×	65 0.9×	48 0.7×	134 2.1×	20	448
M. Paredes-Espinoza Mexico	6	310 1.8×	116 1.1×	46 0.6×	122 1.7×	99 1.6×	7	527
Arthur F. Goldberg United States	9	148 0.9×	126 1.2×	66 0.9×	44 0.6×	117 1.9×	10	496
Fusayuki Omori Japan	13	106 0.6×	177 1.7×	81 1.1×	76 1.1×	114 1.8×	36	458
S Yasuoka Japan	9	69 0.4×	85 0.8×	72 0.9×	84 1.2×	37 0.6×	24	371
A. Wölpl Germany	9	168 1.0×	345 3.2×	69 0.9×	66 0.9×	82 1.3×	31	616
Aswani Yenamandra United States	7	180 1.0×	170 1.6×	32 0.4×	50 0.7×	29 0.5×	9	398
H J Plüss Switzerland	8	118 0.7×	74 0.7×	36 0.5×	61 0.8×	50 0.8×	15	314

Countries citing papers authored by Taub Rn

Since Specialization

Citations

This map shows the geographic impact of Taub Rn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taub Rn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taub Rn more than expected).

Fields of papers citing papers by Taub Rn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taub Rn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taub Rn. The network helps show where Taub Rn may publish in the future.

Co-authorship network of co-authors of Taub Rn

This figure shows the co-authorship network connecting the top 25 collaborators of Taub Rn. A scholar is included among the top collaborators of Taub Rn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taub Rn. Taub Rn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jänne, Pasi A., George R. Simon, Corey J. Langer, et al.. (2005). An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial. Journal of Clinical Oncology. 23(16_suppl). 7067–7067. 7 indexed citations

Jänne, Pasi A., George R. Simon, Christiane Langer, et al.. (2005). P-620 An update of pemetrexed (P) plus gemcitabine (G) asfront-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial. Lung Cancer. 49. S282–S282. 1 indexed citations

Keohan, Mary Louise, et al.. (2005). Phase II study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma. Journal of Clinical Oncology. 23(16_suppl). 9029–9029. 3 indexed citations

Hesdorffer, Mary, Mary Louise Keohan, John A. Chabot, et al.. (2005). Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for malignant peritoneal mesothelioma (MPM). Journal of Clinical Oncology. 23(16_suppl). 7305–7305. 1 indexed citations

Hovey, Elizabeth, et al.. (2004). Phase I/II study of docetaxel (D), gemcitabine (G), Carboplatin (C) in poor prognosis and previously treated patients (pts) with urothelial carcinoma (UTC). Journal of Clinical Oncology. 22(14_suppl). 4580–4580. 2 indexed citations

Keohan, Mary Louise & Taub Rn. (1997). Chemotherapy for advanced sarcoma: therapeutic decisions and modalities.. PubMed. 24(5). 572–9. 44 indexed citations

Gervasoni, James E., Taub Rn, Minshu Yu, et al.. (1992). Homogeneously staining region in anthracycline-resistant HL-60/AR cells not associated with MDR1 amplification.. PubMed. 52(19). 5244–9. 7 indexed citations

Chung, Huimin, Cathy Shea, Scott Z. Fields, et al.. (1990). Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes.. The EMBO Journal. 9(8). 2611–2619. 84 indexed citations

Baker, Mark, et al.. (1985). Increased activity of a specific sialyltransferase in chronic myelogenous leukemia. Blood. 66(5). 1068–1071. 24 indexed citations

10.

Baker, Mark, et al.. (1984). Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood. 63(5). 1194–1197. 24 indexed citations

11.

Stellman, Jeanne Mager, et al.. (1983). Development of an interactive inter-state community hospital based regional tumor registry.. PubMed. 120. 165–9. 2 indexed citations

12.

Rn, Taub, et al.. (1980). Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood. 55(2). 294–298. 20 indexed citations

13.

Shumak, Kenneth H., Mark Baker, Taub Rn, & Morton Coleman. (1980). Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.. PubMed. 40(11). 4048–52. 9 indexed citations

14.

Rn, Taub, et al.. (1980). Serologic characterization of a monkey antiserum to human leukemic myeloblasts. Blood. 56(5). 934–936. 1 indexed citations

15.

Burrows, L, et al.. (1976). Hematologic and immunologic aspects of parabiosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 43(4). 377–84. 2 indexed citations

16.

Severin, C, et al.. (1976). In vivo effects of Concanavalin A. II. Distribution, histopathologic changes, and toxicity.. PubMed. 43(3). 238–47. 4 indexed citations

17.

Chikkappa, G., et al.. (1973). The Kinetic Behaviour of Transfused Donor Bone Marrow Neutrophils and their Precursors in Neutropenic Patients. British Journal of Haematology. 24(3). 287–299. 1 indexed citations

18.

Severin, C, et al.. (1971). Cyclophosphamide-induced immunologic tolerance to skin homografts.. PubMed. 22. 287–8. 13 indexed citations

19.

Rn, Taub. (1970). Effects of heterologous antilymphocyte serum on lymphoid cells labeled with 5-iodo-2-deoxyuridine-125-I.. PubMed. 29(1). 142–4. 3 indexed citations

20.

Rn, Taub. (1969). Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum.. PubMed. 1(1). 445–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact